A new study has exposed significant underrepresentation of researchers and content from the Global South in climate science publications, raising concerns about systemic disparities in academic ...

A version of this essay first appeared in Jess Steier’s newsletter, “Unbiased Science.” Fluoride is having a rough day in the court of public opinion. The National Toxicology Program (NTP), part of ...

LOS ANGELES — The risk of developing long COVID — enduring, sometimes punishing symptoms that linger well after a coronavirus infection — has decreased since the start of the pandemic, a new study ...

Paige, the pioneer in AI-driven pathology solutions designed to improve the fight against cancer, in collaboration with Microsoft, has achieved an important milestone with the publication of a ...

On Tuesday, MeiraGTx Holdings plc (NASDAQ:MGTX) released topline data from its clinical bridging study of AAV-GAD for Parkinson’s disease, MGT-GAD-025. MGT-GAD-025 is a 6-month, three-arm, randomized, ...

TORONTO and HAIFA, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that it has successfully ...

- Analysis of RISE-PD presented at AAN 2025 showed CREXONT treatment significantly improved patients’ Parkinson’s Disease Sleep Scale-2 (PDSS-2) total and sub-scale scores - Treatment with CREXONT ...

Conducted at the Children’s Hospital at Montefiore, a nationally ranked U.S. pediatric hospital, the study, titled “Evaluation of a Line Guard for Pediatric CLABSI Prevention: A Pre-Post Intervention ...